Aytu Biopharma (AYTU) Finished Goods (2019 - 2025)
Historic Finished Goods for Aytu Biopharma (AYTU) over the last 7 years, with Q4 2025 value amounting to $5.6 million.
- Aytu Biopharma's Finished Goods fell 2481.3% to $5.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.6 million, marking a year-over-year decrease of 2481.3%. This contributed to the annual value of $8.9 million for FY2025, which is 4533.33% up from last year.
- Latest data reveals that Aytu Biopharma reported Finished Goods of $5.6 million as of Q4 2025, which was down 2481.3% from $7.9 million recorded in Q3 2025.
- Aytu Biopharma's 5-year Finished Goods high stood at $12.0 million for Q4 2021, and its period low was $5.6 million during Q4 2025.
- Its 5-year average for Finished Goods is $8.5 million, with a median of $8.4 million in 2022.
- In the last 5 years, Aytu Biopharma's Finished Goods soared by 20971.07% in 2021 and then plummeted by 3288.88% in 2022.
- Quarter analysis of 5 years shows Aytu Biopharma's Finished Goods stood at $12.0 million in 2021, then plummeted by 30.08% to $8.4 million in 2022, then grew by 3.73% to $8.7 million in 2023, then fell by 13.66% to $7.5 million in 2024, then decreased by 24.81% to $5.6 million in 2025.
- Its last three reported values are $5.6 million in Q4 2025, $7.9 million for Q3 2025, and $8.9 million during Q2 2025.